Fig. 1From: Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trialStudy flowchart. BMI, body mass index; NAFLD, non-alcoholic fatty liver diseaseBack to article page